| Prev Close | 494.64 |
| Day Low/High | 495.86 / 506.87 |
| 52 Wk Low/High | 441.00 / 664.64 |
Regeneron Pharmaceuticals, Inc. (REGN)
502.60
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 107.13B |
| Market Cap | 52.99B |
| P/E Ratio | 19.71 |
| Div & Yield | N.A. (N.A) |
Latest News
There's No Rush to Purchase Regeneron Stock
The charts are not particularly attractive at this point in time.
Jim Cramer: It's Time for Clear COVID Rules That Make Sense
Outside of the pro sports world, it seems like amateur hour with regard to protocols.
Jim Cramer: Here Are the Biden Stocks
As power has changed hands in the White House, we can expect these names -- and themes -- to benefit.
Jim Cramer: If Government Gets Its Act Together, This Is What Could Happen
The vaccine rollout has been bungled and the nation's in crisis, but you can either dwell on the negativity or look to ingenuity and opportunity. Here's where I see the latter.
How to Play Emergent BioSolutions Right Now
A correction in EBS could soon set up an attractive opportunity.
Looking at 4 Potential Buy Setups This Week
Let's review the charts of DBX, FSLY, REGN, and SPCE.
The Week That Was, Q4 Earnings Expectations, Key Investor and Healthcare Events
This Friday several banks begin the unofficial kickoff of 'earnings season'.
Covid Vaccine Distribution, Jobs, Stimulus Package, Brexit Terms, Investor Days
Most important come Inauguration Day is the seamless transition of leadership over 'Operation Warp Speed'.
November to Remember, Energy Roars, Janet Yellen, Transition, 8 Breakout Stocks
Equity markets have run wild since Oct. 30, and it is the more economically sensitive indices that have really taken flight.
Broadening Market Performance, the Vaccine 'Put', Trading McKesson
Basically, I think we laid out enough reasons for financial markets to revolt, yet they did not.
Jim Cramer: This Is All Playing Out Like a Stephen King Novel
What happens when everyone hunkers down, creating their own de facto stay-in-place lockdown?
Earnings News Will Provide a Respite From Covid and Election Uncertainty
There is little reason to anticipate a sustained bounce at this point, but there are positive aspects to the price action.
Sorrento Therapeutics Stock Is Not That Attractive Now
I like to look for more compelling setups.
Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade
Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.
Jim Cramer: Here's How We're Going to Beat Covid-19
Let's talk about what's happening right now to get this thing under control and what it will look like not that long from now.
Jim Cramer: Here's Why the President Is Gambling With Stimulus
The market is reflecting a triumph of big business over small business, and here's what that means for individual stocks.
Jim Cramer: The President's Behavior Towards Covid-19
I know that Trump's going to blunt our community mask initiative because who needs masks if it isn't a big deal if you are sick?
Trump's Health and the Market, Charts That Matter, Nvidia News, URI Breaks Out
Even more important than fiscal support moving forward would be the concept of Covid-19 very soon being effectively treatable for the public.
Real Money Post Industrial Average Outperforms Major Indexes in September
The RMPIA rose 13.8% during the quarter, leaving it up just shy of 29% on a year-to-date basis, thanks to performance by CRM, AAPL , NKE and TMO.
Jim Cramer: Does Everyone Out There Perceive That Everything Is a Win?
It's remarkable to see such excitement based on totally contradictory theories and themes.
Strength in Regeneron Stock May Not Last Long
The charts of REGN could use more than media coverage.
Jim Cramer: What Investors Should Watch and Expect This Week
This is what's known as a positioning week, and starting Monday you're going to hear a ton of things.
Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.
Neither candidate seems to be the enemy of the market -- at least not yet.
Kass: Does a Possible Biden Bump in Equities Lie Ahead?
I would not view what appears to be an increasingly likely Democratic victory as a reason to sell stocks.
Will We See a 'Biden Bump' Which May Levitate Stocks Throughout the Balance of the Year?
* The 2016 Presidential election provided the contrary - a Trump win and an advancing stock market * The 2020 Presidential election may provide another contrary - a Biden win and an advancing market * President Trump's path to victory is narrowing *...
Debate Spin, Slowing Recovery, Stimulus Hope, Notes on Regeneron, Disney, Tesla
Markets now look to Treasury Secretary Mnuchin and Speaker Pelosi to do something.
